During the past decade, Sameshima Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sameshima Hospital" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Pfizer" with 5 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Janssen-Cilag Ltd." with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sameshima Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sameshima Hospital" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (1 trials), "Fistulizing Crohns Disease" (1 trials) and "Perianal Crohns Disease" (1 trials). Many other conditions were trialed in "Sameshima Hospital" in a lesser frequency.

Most popular intervention types in "Sameshima Hospital" are "Drug" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Mirikizumab" (5 trials), "Etrasimod" (4 trials), "Guselkumab" (3 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sameshima Hospital" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Sameshima Hospital". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Sameshima Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sameshima Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".